United States Biotechnology & Medical Research

Osmotica Pharmaceuticals PLC (OSMT)

Track

Track

Ticker: OSMT Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Osmotica Pharmaceuticals PLC. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.5
Harsaul Foundation Large shareholder
Transaction date
Sale
Price
42.17
Quantity 84,812 -20.0%
Value US$984,194
1.5
Altchem Ltd Large shareholder
Transaction date
Sale
Price
189.62
Quantity 26,090 -20.0%
Value US$3,317,563
1.5
Harsaul Foundation Large shareholder
Transaction date
Sale
Price
160.62
Quantity 63,845 +25.1%
Value US$2,983,749
1.5
Altchem Ltd Large shareholder
Transaction date
Sale
Price
0.05
Quantity 9,363,760 -49.1%
Value US$431,669
1.5
Altchem Ltd Large shareholder
Transaction date
Sale
Price
0.06
Quantity 3,421,537 -15.2%
Value US$221,031
1.5
Harsaul Foundation Large shareholder
Transaction date
Sale
Price
0.06
Quantity 3,421,537 -15.2%
Value US$221,031
1.5
Altchem Limited Affiliate
Transaction date
Proposed sale
Price
0.07
Quantity 22,485,297
Value US$1,597,971
1.5
Burgstahler David F Venture Investor/General Partner
Transaction date
Proposed sale
Price
0.09
Quantity 670,694
Value US$60,362
Dean Thompson Venture Investor/General Partner
Transaction date
Proposed sale
Price
0.10
Quantity 879,004
Value US$87,900
1.5
Venkataraman Sriram Venture Investor/General Partner
Transaction date
Proposed sale
Price
0.10
Quantity 160,078
Value US$16,008
Dean Thompson Venture Investor/General Partner
Transaction date
Proposed sale
Price
0.14
Quantity 767,515
Value US$105,840
1.5
Venkataraman Sriram Venture Investor/General Partner
Transaction date
Proposed sale
Price
0.14
Quantity 140,767
Value US$19,708
1.5
Burgstahler David F Venture Investor/General Partner
Transaction date
Proposed sale
Price
0.14
Quantity 767,515
Value US$105,840
MARKISON BRIAN A Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.55
Quantity 850,000 +40.0%
Value US$1,317,500
Schaub James EVP and COO Officer
Transaction date
Purchase
Price
1.55
Quantity 150,000 +38.5%
Value US$232,500
1.5
Venkataraman Sriram Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.55
Quantity 8,000,000 +50.9%
Value US$12,400,000
1.5
Burgstahler David F Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.55
Quantity 8,000,000 +50.9%
Value US$12,400,000
Schaub James EVP and COO Officer
Transaction date
Purchase
Price
1.07
Quantity 93,800 +30.1%
Value US$100,366
1.5
Burgstahler David F Large shareholder
Transaction date
Purchase
Price
5.00
Quantity 1,250,000 +8.6%
Value US$6,250,000
1.5
Altchem Ltd Large shareholder
Transaction date
Purchase
Price
5.00
Quantity 1,250,000 +5.9%
Value US$6,250,000
1.5
Venkataraman Sriram Large shareholder
Transaction date
Purchase
Price
5.00
Quantity 1,250,000 +8.6%
Value US$6,250,000
1.5
Harsaul Foundation Large shareholder
Transaction date
Purchase
Price
5.00
Quantity 1,250,000 +5.9%
Value US$6,250,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-10-23 2023-10-20 S Sale
1.5
Harsaul Foundation
Large shareholder
84,812 -20.0%
42.17
US$984,194 		84,812 -20.0% 42.17 US$984,194
2023-10-23 2023-10-20 S Sale
1.5
Altchem Ltd
Large shareholder
26,090 -20.0%
189.62
US$3,317,563 		26,090 -20.0% 189.62 US$3,317,563
2023-10-23 2023-10-19 S Sale
1.5
Harsaul Foundation
Large shareholder
63,845 +25.1%
160.62
US$2,983,749 		63,845 +25.1% 160.62 US$2,983,749
2023-10-23 2023-10-19 S Sale
1.5
Altchem Ltd
Large shareholder
9,363,760 -49.1%
0.05
US$431,669 		9,363,760 -49.1% 0.05 US$431,669
2023-10-20 2023-10-18 S Sale
1.5
Altchem Ltd
Large shareholder
3,421,537 -15.2%
0.06
US$221,031 		3,421,537 -15.2% 0.06 US$221,031
2023-10-20 2023-10-18 S Sale
1.5
Harsaul Foundation
Large shareholder
3,421,537 -15.2%
0.06
US$221,031 		3,421,537 -15.2% 0.06 US$221,031
2023-10-18 2023-10-18 PrS Proposed sale
1.5
Altchem Limited

Affiliate
22,485,297
0.07
US$1,597,971 		22,485,297 0.07 US$1,597,971
2023-09-25 2023-09-25 PrS Proposed sale
1.5
Burgstahler David F

Venture Investor/General Partner
670,694
0.09
US$60,362 		670,694 0.09 US$60,362
2023-08-30 2023-08-30 PrS Proposed sale
Dean Thompson

Venture Investor/General Partner
879,004
0.10
US$87,900 		879,004 0.10 US$87,900
2023-08-30 2023-08-30 PrS Proposed sale
1.5
Venkataraman Sriram

Venture Investor/General Partner
160,078
0.10
US$16,008 		160,078 0.10 US$16,008
2023-08-24 2023-08-24 PrS Proposed sale
Dean Thompson

Venture Investor/General Partner
767,515
0.14
US$105,840 		767,515 0.14 US$105,840
2023-08-24 2023-08-24 PrS Proposed sale
1.5
Venkataraman Sriram

Venture Investor/General Partner
140,767
0.14
US$19,708 		140,767 0.14 US$19,708
2023-08-24 2023-08-24 PrS Proposed sale
1.5
Burgstahler David F

Venture Investor/General Partner
767,515
0.14
US$105,840 		767,515 0.14 US$105,840
2022-08-09 2022-08-08 B Purchase
MARKISON BRIAN A

Chief Executive Officer

Executive Director
850,000 +40.0%
1.55
US$1,317,500 		850,000 +40.0% 1.55 US$1,317,500
2022-08-09 2022-08-08 B Purchase
Avista Healthcare Partners, L.P.
Large shareholder
8,000,000 +50.9%
1.55
US$12,400,000 		8,000,000 +50.9% 1.55 US$12,400,000
2022-08-09 2022-08-08 B Purchase
Schaub James

EVP and COO

Officer
150,000 +38.5%
1.55
US$232,500 		150,000 +38.5% 1.55 US$232,500
2022-08-09 2022-08-08 B Purchase
1.5
Venkataraman Sriram
Non-Executive Director Large shareholder
8,000,000 +50.9%
1.55
US$12,400,000 		8,000,000 +50.9% 1.55 US$12,400,000
2022-08-09 2022-08-08 B Purchase
1.5
Burgstahler David F
Non-Executive Director Large shareholder
8,000,000 +50.9%
1.55
US$12,400,000 		8,000,000 +50.9% 1.55 US$12,400,000
2021-12-20 2021-12-16 B Purchase
Schaub James

EVP and COO

Officer
93,800 +30.1%
1.07
US$100,366 		93,800 +30.1% 1.07 US$100,366
2020-01-15 2020-01-13 B Purchase
1.5
Avista Capital Partners III GP, L.P.
Large shareholder
1,250,000 +8.6%
5.00
US$6,250,000 		1,250,000 +8.6% 5.00 US$6,250,000
2020-01-15 2020-01-13 B Purchase
1.5
Burgstahler David F
Large shareholder
1,250,000 +8.6%
5.00
US$6,250,000 		1,250,000 +8.6% 5.00 US$6,250,000
2020-01-15 2020-01-13 B Purchase
1.5
Altchem Ltd
Large shareholder
1,250,000 +5.9%
5.00
US$6,250,000 		1,250,000 +5.9% 5.00 US$6,250,000
2020-01-15 2020-01-13 B Purchase
1.5
Venkataraman Sriram
Large shareholder
1,250,000 +8.6%
5.00
US$6,250,000 		1,250,000 +8.6% 5.00 US$6,250,000
2020-01-15 2020-01-13 B Purchase
1.5
Harsaul Foundation
Large shareholder
1,250,000 +5.9%
5.00
US$6,250,000 		1,250,000 +5.9% 5.00 US$6,250,000
Explore more

More insider trading research around Osmotica Pharmaceuticals PLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America